ArticleCanadian journal of kidney health and disease2021

A Canadian Study of Cisplatin Metabolomics and Nephrotoxicity (ACCENT): A Clinical Research Protocol.

Anshika Jain et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.